4/4
04:15 pm
holx
Wayde McMillan Elected to Hologic Board of Directors
Low
Report
Wayde McMillan Elected to Hologic Board of Directors
4/3
04:30 pm
holx
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025
Low
Report
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025
3/31
09:34 pm
holx
Hologic (HOLX) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]
Low
Report
Hologic (HOLX) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]
3/7
01:38 pm
holx
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report? [Yahoo! Finance]
3/4
12:48 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $70.00. They now have a "neutral" rating on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $70.00. They now have a "neutral" rating on the stock.
3/3
08:12 am
holx
Hologic, Inc. (NASDAQ: HOLX) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.
2/25
07:07 pm
holx
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference [Yahoo! Finance]
Low
Report
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference [Yahoo! Finance]
2/25
08:15 am
holx
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference
Low
Report
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference
2/20
03:58 am
holx
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software [Yahoo! Finance]
Low
Report
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software [Yahoo! Finance]
2/20
03:00 am
holx
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software
Low
Report
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software
2/18
08:32 am
holx
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay [Yahoo! Finance]
Low
Report
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay [Yahoo! Finance]
2/18
08:08 am
holx
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
Low
Report
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
2/9
09:50 am
holx
Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price [Yahoo! Finance]
Low
Report
Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price [Yahoo! Finance]
2/7
08:10 am
holx
Why Hologic (HOLX) Stock Went Down On Thursday? [Yahoo! Finance]
Low
Report
Why Hologic (HOLX) Stock Went Down On Thursday? [Yahoo! Finance]
2/7
06:17 am
holx
Hologic, Inc. (NASDAQ: HOLX) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
2/6
01:32 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $90.00 price target on the stock, down previously from $95.00.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $90.00 price target on the stock, down previously from $95.00.
2/6
12:42 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Royal Bank of Canada from $88.00 to $85.00. They now have a "sector perform" rating on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Royal Bank of Canada from $88.00 to $85.00. They now have a "sector perform" rating on the stock.
2/6
12:07 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
2/6
11:49 am
holx
Here's Why Hologic (HOLX) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Hologic (HOLX) is a Strong Momentum Stock [Yahoo! Finance]
2/6
11:01 am
holx
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Evercore ISI from $76.00 to $73.00. They now have an "in-line" rating on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Evercore ISI from $76.00 to $73.00. They now have an "in-line" rating on the stock.
2/6
10:13 am
holx
Hologic (HOLX) Q1 Earnings Surpass Estimates [Yahoo! Finance]
Low
Report
Hologic (HOLX) Q1 Earnings Surpass Estimates [Yahoo! Finance]
2/6
10:13 am
holx
Hologic Inc (HOLX) Q1 2025 Earnings Call Highlights: Strong Diagnostics Growth Amid Breast ... [Yahoo! Finance]
Low
Report
Hologic Inc (HOLX) Q1 2025 Earnings Call Highlights: Strong Diagnostics Growth Amid Breast ... [Yahoo! Finance]
2/6
10:13 am
holx
Hologic: Fiscal Q1 Earnings Snapshot [Yahoo! Finance]
Low
Report
Hologic: Fiscal Q1 Earnings Snapshot [Yahoo! Finance]
2/6
10:13 am
holx
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance [Yahoo! Finance]
Low
Report
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance [Yahoo! Finance]
2/6
10:13 am
holx
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]